X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1186) 1186
Conference Proceeding (527) 527
Book Review (102) 102
Publication (44) 44
Book Chapter (9) 9
Book / eBook (5) 5
Patent (3) 3
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (724) 724
humans (677) 677
endocrinology & metabolism (556) 556
clinical neurology (502) 502
female (462) 462
male (429) 429
adult (364) 364
multiple sclerosis (251) 251
neurosciences (237) 237
middle aged (226) 226
adolescent (169) 169
magnetic resonance imaging (147) 147
diabetes (139) 139
type 1 diabetes (139) 139
mellitus (106) 106
aged (98) 98
child (98) 98
medicine & public health (97) 97
abridged index medicus (95) 95
treatment outcome (91) 91
diabetes mellitus, type 1 - immunology (84) 84
animals (83) 83
follow-up studies (83) 83
insulin (76) 76
disability (73) 73
risk factors (73) 73
research (70) 70
neurology (67) 67
disease (66) 66
mice (66) 66
double-blind (64) 64
care and treatment (63) 63
young adult (62) 62
multiple sclerosis - drug therapy (60) 60
disability evaluation (58) 58
immunology (58) 58
interferon-beta - therapeutic use (58) 58
diabetes mellitus, type 1 - drug therapy (57) 57
diabetes mellitus (56) 56
time factors (56) 56
analysis (55) 55
brain - pathology (55) 55
multiple sclerosis - physiopathology (55) 55
psychiatry (54) 54
children (53) 53
diabetes mellitus, type 1 - genetics (53) 53
diagnosis (52) 52
type 2 diabetes (51) 51
internal medicine (50) 50
disease progression (49) 49
risk (49) 49
metabolic diseases (48) 48
mri (47) 47
multiple sclerosis - pathology (47) 47
prospective studies (47) 47
therapy (46) 46
diabetes mellitus, type 1 - blood (45) 45
double-blind method (44) 44
health aspects (43) 43
italy (43) 43
diabetes mellitus, type 1 - epidemiology (42) 42
multiple sclerosis - diagnosis (42) 42
medicine, general & internal (41) 41
guidelines (40) 40
insulin - therapeutic use (40) 40
multiple sclerosis - complications (40) 40
multiple sclerosis, relapsing-remitting - drug therapy (40) 40
autoantibodies (39) 39
neuroradiology (39) 39
antibodies (38) 38
interferon beta-1a (38) 38
autoimmunity (37) 37
case-control studies (37) 37
child, preschool (37) 37
hypoglycemic agents - therapeutic use (37) 37
prevention (37) 37
interferon beta (36) 36
cohort studies (35) 35
recurrence (35) 35
diabetes mellitus, type 1 - prevention & control (34) 34
incidence (34) 34
patients (34) 34
age of onset (33) 33
drug therapy (33) 33
glucose (33) 33
placebo-controlled trial (33) 33
retrospective studies (33) 33
endocrinology (32) 32
radiology, nuclear medicine & medical imaging (32) 32
beta-cell function (31) 31
impairment (31) 31
multicenter (31) 31
trial (31) 31
brain (30) 30
clinical trials (30) 30
iddm (30) 30
interferon beta-1b (30) 30
pregnancy (30) 30
prevalence (30) 30
immunologic factors - therapeutic use (29) 29
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Diabetes, ISSN 0012-1797, 11/2011, Volume 60, Issue 11, pp. 3067 - 3072
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2015, Volume 373, Issue 22, pp. 2117 - 2128
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2016, Volume 375, Issue 4, pp. 323 - 334
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2017, Volume 377, Issue 13, pp. 1228 - 1239
This trial, which compared once-weekly exenatide plus usual care with usual care alone in patients with type 2 diabetes with or without previous cardiovascular... 
MEDICINE, GENERAL & INTERNAL | RISK | EVENT LOWERING EXSCEL | GLUCOSE CONTROL | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Male | Exenatide | Peptides - administration & dosage | Incidence | Cardiovascular Diseases - complications | Hypoglycemic Agents - administration & dosage | Injections, Subcutaneous | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Venoms - administration & dosage | Female | Diabetes Mellitus, Type 2 - complications | Double-Blind Method | Drug Administration Schedule | Venoms - adverse effects | Kaplan-Meier Estimate | Diabetes Mellitus, Type 2 - blood | Least-Squares Analysis | Aged | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Peptides - adverse effects | Type 2 diabetes | Usage | Patient outcomes | Outcome and process assessment (Health Care) | Reports | Dosage and administration | Drug therapy | Observations | Myocardial infarction | Cerebral infarction | Diabetes mellitus | Pancreatitis | Amylin | Cardiovascular disease | Patients | Thyroid carcinoma | Studies | Side effects | Pancreatic carcinoma | Pancreatic cancer | Diabetes | Health risk assessment | Heart diseases | Endocrinology | Pharmaceuticals | Index Medicus | Abridged Index Medicus | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article